Search research articles
Contact Us
Filters
Showing results (31-40 of 142) with videos related to
Page
of 15
Sort By:
Journal of Neuroimmunology
|
February 19, 2008
Depletion of autoreactive B-lymphocytes by a recombinant myelin oligodendrocyte glycoprotein-based immunotoxin
Thomas Nachreiner, Florian Kampmeier, Theo Thepen, et al.
Protein Expression and Purification
|
April 18, 2003
Secretion of functional anti-CD30-angiogenin immunotoxins into the supernatant of transfected 293T-cells
Michael Stöcker, Mehmet K Tur, Stefanie Sasse, et al.
Cancers
|
March 13, 2024
The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma
Enric Arasanz Picher, Muhammad Wahajuddin, Stefan Barth, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
October 27, 2017
Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer
Eden R Padayachee, Fleury Augustin Nsole Biteghe, Zaria Malindi, et al.
Nature Protocols
|
October 13, 2019
One-step site-specific antibody fragment auto-conjugation using SNAP-tag technology
Ahmad Fawzi Hussain, Paul A Heppenstall, Florian Kampmeier, et al.
Biomedicines
|
June 22, 2018
Human Granzyme B Based Targeted Cytolytic Fusion Proteins
Precious Hlongwane, Neelakshi Mungra, Suresh Madheswaran, et al.
BMC Biotechnology
|
February 18, 2016
Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen
Diana Klose, Ute Saunders, Stefan Barth, et al.
Current Cancer Drug Targets
|
November 11, 2008
Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2
Ulrich Wullner, Inga Neef, Andreas Eller, et al.
International Journal of Cancer
|
November 16, 2010
In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA' in a human acute myeloid leukemia xenograft tumor model
Mehmet Kemal Tur, Michael Huhn, Edgar Jost, et al.
Immunology Letters
|
June 6, 2015
Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies
Andre Ten Haaf, Sibylle Pscherer, Katharina Fries, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 142) with videos related to
Sort By:
Page
of 15
Journal of Neuroimmunology
|
February 19, 2008
Depletion of autoreactive B-lymphocytes by a recombinant myelin oligodendrocyte glycoprotein-based immunotoxin
Thomas Nachreiner, Florian Kampmeier, Theo Thepen, et al.
Protein Expression and Purification
|
April 18, 2003
Secretion of functional anti-CD30-angiogenin immunotoxins into the supernatant of transfected 293T-cells
Michael Stöcker, Mehmet K Tur, Stefanie Sasse, et al.
Cancers
|
March 13, 2024
The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma
Enric Arasanz Picher, Muhammad Wahajuddin, Stefan Barth, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
October 27, 2017
Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer
Eden R Padayachee, Fleury Augustin Nsole Biteghe, Zaria Malindi, et al.
Nature Protocols
|
October 13, 2019
One-step site-specific antibody fragment auto-conjugation using SNAP-tag technology
Ahmad Fawzi Hussain, Paul A Heppenstall, Florian Kampmeier, et al.
Biomedicines
|
June 22, 2018
Human Granzyme B Based Targeted Cytolytic Fusion Proteins
Precious Hlongwane, Neelakshi Mungra, Suresh Madheswaran, et al.
BMC Biotechnology
|
February 18, 2016
Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen
Diana Klose, Ute Saunders, Stefan Barth, et al.
Current Cancer Drug Targets
|
November 11, 2008
Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2
Ulrich Wullner, Inga Neef, Andreas Eller, et al.
International Journal of Cancer
|
November 16, 2010
In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA' in a human acute myeloid leukemia xenograft tumor model
Mehmet Kemal Tur, Michael Huhn, Edgar Jost, et al.
Immunology Letters
|
June 6, 2015
Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies
Andre Ten Haaf, Sibylle Pscherer, Katharina Fries, et al.
Page
of 15